Prostate cancer: Radiopharmaceuticals. Part 1 - Radium-223

December 06, 2023 00:30:53
Prostate cancer: Radiopharmaceuticals. Part 1 - Radium-223
COR2ED - Oncology Medical Conversation
Prostate cancer: Radiopharmaceuticals. Part 1 - Radium-223

Dec 06 2023 | 00:30:53

/

Show Notes

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss the latest developments in the field of radiopharmaceuticals and their use in Prostate Cancer. They are also joined by guest speaker Dr. Neal Shore (Carolina Urologic Research Center, North Carolina, USA).

In this first episode, the experts focus on the alpha emitter, Radium-223 which received regulatory approval on the basis of the phase 3 ALSYMPCA trial in patients with metastatic castration resistant prostate cancer (mCRPC) and symptomatic bone metastases. They consider mechanism of action and discuss key results from the trial and the safety profile.

The experts also review the ERA-223 and PEACE-III randomised trials which investigated the use of Radium-223 in combination with next generation androgen receptor inhibitors (ARIs). A number of real-world evidence studies are also reviewed as the experts consider where radium-223 fits into the overall treatment sequence for mCRPC patients. Radiation safety and general considerations for delivering therapy with radiopharmaceuticals are also discussed.

Other Episodes

Episode

December 06, 2023 00:21:50
Episode Cover

Prostate cancer: PARP inhibitors. Part 1 - PARPi monotherapy; US and EU perspectives

Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...

Listen

Episode

December 06, 2023 00:31:03
Episode Cover

Prostate cancer: Genetic testing and PARP inhibitors in prostate cancer

COR2ED Medical Education: Joanne Chien, Nurse Practitioner specialising in urologic cancers at Stanford Health Care in Palo Alto, California, and Dr Alexander Wyatt, Assistant...

Listen

Episode

December 06, 2023 00:20:43
Episode Cover

Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute...

Listen